Cancer Policy NIH suspends new embryonic stem cell line submissions January 30, 2026Vol.52 No.04By Sara Willa Ernst
Cancer Policy CMS to enter negotiations with drugmakers over the price of four cancer medications January 30, 2026Vol.52 No.04By Sara Willa Ernst
Cancer Policy Tens of thousands of healthcare workers strike across the country January 30, 2026Vol.52 No.04By Sara Willa Ernst
Cancer Policy FDA delays drug reviews in new voucher program amid safety, efficacy concerns January 30, 2026Vol.52 No.04By Claire Marie Porter
In Brief Dario Altieri to step down as president of The Wistar Institute January 30, 2026Vol.52 No.04
In Brief Gustavo Rivero to lead translational research for hematologic malignancies at Tampa General Hospital Cancer Institute January 30, 2026Vol.52 No.04
In Brief Jennifer Dahne named director of Research Innovation and Integration at MUSC January 30, 2026Vol.52 No.04
In Brief Navid Hafez named director of clinical research of the START Center Los Angeles January 30, 2026Vol.52 No.04
